Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins.
Anja
A
Schneider
Mikael
M
Simons
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000201:enzymology*; D000818:Animals; D000069059:Atorvastatin; D006538:Heptanoic Acids / Q000494:pharmacology*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D018696:Neuroprotective Agents; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology*
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents; D011758:Pyrroles; D000069059:Atorvastatin; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019789:biliverdin reductase